Pyrazolam is a benzodiazepine derivative originally developed by a team lead by Leo Sternbach at Hoffman-La Roche in the 1970s and subsequently rediscovered and sold as a research chemical starting in 2012. It is mainly an anxiolytic but it has also shown anticonvulsant and hypnotic effects at high doses.
This page contains content from the copyrighted Wikipedia article "Pyrazolam"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
